Convergent Finance
VC Fund
Mumbai, India
Convergent Finance is a VC fund in Mumbai focused on Manufacturing and Biotechnology. Convergent is an investment partnership at the forefront of bringing together Ideas, Capital and passionate Entrepreneurs. We help great companies transform into global leaders. The Convergent investment process involves identifying proprietary platform and bolt-on opportunities, speed of execution and a relentless focus on performance improvement.The Convergent value investing approach believes in paying fair and reasonable valuations through bilaterally negotiated transactions.
- Total investments:
- 13
- Last investment:
- Lead investor:
- 92%
Last updated:
For AI agents: llms.txt
Industries Convergent Finance invests in
Stages Convergent Finance invests in
Countries Convergent Finance invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Private Equity
- $14M–$24M
- Post-IPO Equity
- $9.7M–$36M
Investment Focus
Industry
- Manufacturing 6 (46%)
- Biotechnology 3 (23%)
- Pharmaceutical 3 (23%)
- Cosmetics 2 (15%)
- Health Care 2 (15%)
Stage
- Post-IPO Equity 8 (62%)
- Private Equity 2 (15%)
- Series A 1 (8%)
- Post-IPO Secondary 1 (8%)
Country
- India 11 (85%)
- United Kingdom 1 (8%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Harsha Raghavan
Founder & Managing Partner
|
Founder & Managing Partner | Total investments: 11 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Camlin Fine Sciences
|
Camlin Fine Sciences is a provider of high-quality shelf life extension solutions including antioxidants, aroma ingredients and performance chemicals. | Post-IPO Equity / Sep 15, 2023 | |
Agilitas
|
Agilitas Sports operates as a sportswear and athleisure solutions platform. | $52.3M / Series A / May 15, 2023 | |
Fly91
|
Fly91provides reliable, comfortable and affordable flights. | $24.3M / Private Equity / Jan 09, 2023 | |
Jagsonpal Pharmaceuticals
|
Jagsonpal Pharmaceuticals is a pharma company that specializes in the development of bulk drugs and pharmaceutical formulations. It has a presence in gynaecology, IVF specialization, and orthopedics. Their drug engagement is in women's health, pain, analgesics, and general medicine. | $35.9M / Post-IPO Equity / Feb 21, 2022 | |
Welspun India
|
Welspun India is a retailer and manufacturer of textile goods. It is Asia's largest and the 2nd largest Terry Towel producer in the world that exports more than 94 percent of its home textile products to more than 50 countries. Its products are packed in innovative patent-pending packaging that reduces space requirements by 33% during shipmentvis-à-vis traditional packaging. It was formerly known as Welspun Polyester India Limited.It was founded in 1985 and is headquartered in Mumbai, India. | $21.7M / Post-IPO Equity / Nov 01, 2021 | |
Onward Technologies
|
Headquartered in Mumbai, with prominent global presence in North America & Europe, and state-of-the-art offshore delivery centres (ODC) in India, we support businesses in focused verticals of Transportation & Mobility, Industrial Equipment & Heavy Machinery, and Healthcare & Lifesciences. With a scalable outsourcing/offshoremodel across 6 countries, a fast-growing team of 2800+ employees, and long-term customer associations, we accelerate innovation and maximize returns on R&D investments for our marquee customers. With two decades of expertise in Mechanical Engineering capabilities, we have augmented our prowess in two lines of business (LOB) in Digital & Data Engineering and Electronics & Embedded Engineering for our customers. Founded in 1991, the company has been listed on both NSE and BSE, since 1995. | $9.7M / Post-IPO Equity / May 27, 2021 | |
Borosil Renewables
|
Borosil is a market leader for laboratory glassware for India’s leading pharmaceutical and healthcare sectors. Borosil plans to combine its technological expertise in speciality glass production with Klasspack’s experience in glass ampoule and tubular glass vial production. | $27.2M / Post-IPO Equity / Dec 18, 2020 | |
ADF Foods
|
ADF Foods focus on prepared ethnic food offering ready-to-eat items, ready-to-cook items, sauces, pickles, pastes, dips and frozen foods. | $11.9M / Post-IPO Secondary / Dec 04, 2020 | |
SeQuent Scientific
|
SeQuent Scientific Limited is an India-based integrated pharmaceutical company. The Company engaged in developing products and services for a variety of industries, such as pharmaceuticals, agrochemicals, plastics, personal care (cosmetics). The Company operates in three segments include active pharmaceutical ingredients (API), Analytical Servicesand Animal Health. | $15.5M / Post-IPO Equity / Jun 29, 2020 | |
Viyash Lifesciences
|
Viyash Lifesciences is an India-based integrated pharmaceutical company. The Company engaged in developing products and services for a variety of industries, such as pharmaceuticals, agrochemicals, plastics, personal care (cosmetics). The Company operates in three segments include active pharmaceutical ingredients (API), Analytical Services andAnimal Health. | $17.2M / Post-IPO Equity / Jun 29, 2020 | |
| See all 13 investments → | |||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Convergent Finance invest in?
Convergent Finance invests primarily in Manufacturing, Biotechnology and Pharmaceutical startups, most often at Post-IPO Equity and Private Equity stage. Most of the 13 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Convergent Finance's check size?
Convergent Finance typically joins rounds of $14M–$24M at Private Equity and $9.7M–$36M at Post-IPO Equity. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Convergent Finance participates in.
How do I contact Convergent Finance?
Public channels for Convergent Finance include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Convergent Finance?
The team at Convergent Finance includes Harsha Raghavan (Founder & Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
